4
Changes in Ownership
Dermata Therapeutics, Inc. Filed Acc 0000905718-21-001096
Senior VP, Development acquired 2,439 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nardo Christopher J. Senior VP, Development | 2021-08-17 | Conversion | +2,439 | 2,439 | I | ||
| Derivatives | |||||||
| Nardo Christopher J. Senior VP, Development | 2021-08-17 | Conversion · Series 1 Preferred Stock | −50,000 | 0 | I | ||
Loading xslF345X03/dermata_fm4aug172021.xml…